Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia
- 31 January 1993
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 65 (1) , 32-34
- https://doi.org/10.1016/0165-4608(93)90055-q
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- THE CLINICAL APPLICATION OF MOLECULAR TECHNIQUES IN PHILADELPHIA‐POSITIVE LEUKAEMIABritish Journal of Haematology, 1992
- The use of the polymerase chain reaction for the detection of minimal residual malignant disease [editorial]Blood, 1991
- Review of clinical, cytogenetic, and molecular aspects of Ph-negative CMLCancer Genetics and Cytogenetics, 1991
- Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapseBlood, 1991
- Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ HybridizationScience, 1990
- False-positive results with PCR to detect leukaemia-specific transcriptThe Lancet, 1990
- Detection of the Philadelphia chromosome in interphase nucleiCytogenetic and Genome Research, 1990
- Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemiaHuman Genetics, 1989
- MINIMAL RESIDUAL LEUKAEMIA IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER T-CELL DEPLETED BONE-MARROW TRANSPLANTATIONThe Lancet, 1989
- Three‐color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequencesCytometry, 1989